Richard Alcock
Corporate Officer/Principal bij Office of Technology Development
Profiel
Rich oversees the Material Transfer Agreements (MTA) process within the Technology Transactions group of OTD.
His team manages all of Harvard’s material transfer requests, which govern the flow of research materials both to and from Harvard researchers.
He is also responsible for negotiating and signing confidential disclosure agreements handled by OTD, as well as the licensing of Harvard materials to for-profit entities.
Rich joined OTD in 2012 after spending three years at Partners HealthCare in its Office of Research Ventures & Licensing.
He has also worked in the general counsel’s office at Critical Therapeutics, Inc. and in the business law departments of Boston law firms Hutchins, Wheeler and Dittmar, PC, and Hale and Dorr, LLP.
Rich holds a JD from Harvard Law School and a BA from Boston College.
Actieve functies van Richard Alcock
Bedrijven | Functie | Begin |
---|---|---|
Office of Technology Development
Office of Technology Development Investment ManagersFinance Office of Technology Development (Office of Technology Development) is a venture capital subsidiary of Harvard University founded in 2007. The firm is headquartered in Cambridge, Massachusetts. | Corporate Officer/Principal | 01-01-2012 |
Eerdere bekende functies van Richard Alcock
Bedrijven | Functie | Einde |
---|---|---|
Critical Therapeutics, Inc. | Consultant / Adviseur | - |
Opleiding van Richard Alcock
Harvard Law School | Graduate Degree |
Boston College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Office of Technology Development
Office of Technology Development Investment ManagersFinance Office of Technology Development (Office of Technology Development) is a venture capital subsidiary of Harvard University founded in 2007. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Critical Therapeutics, Inc. | Health Technology |